CapsoVision, Inc. (CV)
NASDAQ: CV · Real-Time Price · USD
4.290
+0.070 (1.66%)
Aug 7, 2025, 4:00 PM - Market closed

Verve Therapeutics Analyst Ratings

Total Analysts
1
Consensus Rating
Buy
Price Target
$5.00
Upside
+16.55%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Benchmark
Benchmark
Buy
Initiates
$5
BuyInitiates$5+16.55%Jul 28, 2025